Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Janux Therapeutics, Inc. | Vice President, Accounting | Common Stock | 14K | $803K | $57.37 | Jan 2, 2025 | Direct |
Janux Therapeutics, Inc. | Vice President, Accounting | Stock option (right to buy) | 31.5K | Jan 2, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
JANX | Janux Therapeutics, Inc. | Jan 2, 2025 | 2 | $0 | 4 | Jan 3, 2025 | Vice President, Accounting |
JANX | Janux Therapeutics, Inc. | Aug 8, 2024 | 0 | $0 | 3 | Aug 9, 2024 | Vice President, Accounting |